A Study Evaluating Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of HSK3486 Single Bolus Dose Followed With a 30 Minute Constant Infusion in Healthy Male Subjects
Clinical trial NCT04029766 · COMPLETED
Trial details
- NCT number
- NCT04029766
- Sponsor
- Sichuan Haisco Pharmaceutical Group Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-10
- Primary completion
- 2015-12-14
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.